Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-12